Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-09

FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industires Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's risendronate sodium as an original application for a generic product, with indications for osteoporosis-related conditions and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

ORIG AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)